nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftaroline fosamil—Phlebitis—Carboplatin—bone cancer	0.0683	0.0683	CcSEcCtD
Ceftaroline fosamil—Pain—Carboplatin—bone cancer	0.0247	0.0247	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Cisplatin—bone cancer	0.0233	0.0233	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Carboplatin—bone cancer	0.0229	0.0229	CcSEcCtD
Ceftaroline fosamil—Transaminases increased—Epirubicin—bone cancer	0.0201	0.0201	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Cisplatin—bone cancer	0.02	0.02	CcSEcCtD
Ceftaroline fosamil—Transaminases increased—Doxorubicin—bone cancer	0.0186	0.0186	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Cisplatin—bone cancer	0.0157	0.0157	CcSEcCtD
Ceftaroline fosamil—Renal failure—Cisplatin—bone cancer	0.0131	0.0131	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Cisplatin—bone cancer	0.0126	0.0126	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Cisplatin—bone cancer	0.0121	0.0121	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Epirubicin—bone cancer	0.012	0.012	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Cisplatin—bone cancer	0.0118	0.0118	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Cisplatin—bone cancer	0.0117	0.0117	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Doxorubicin—bone cancer	0.0111	0.0111	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Cisplatin—bone cancer	0.0108	0.0108	CcSEcCtD
Ceftaroline fosamil—Erythema—Cisplatin—bone cancer	0.0104	0.0104	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Cisplatin—bone cancer	0.0104	0.0104	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Epirubicin—bone cancer	0.0103	0.0103	CcSEcCtD
Ceftaroline fosamil—Anaemia—Cisplatin—bone cancer	0.0096	0.0096	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Doxorubicin—bone cancer	0.00952	0.00952	CcSEcCtD
Ceftaroline fosamil—Convulsion—Cisplatin—bone cancer	0.009	0.009	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00878	0.00878	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Cisplatin—bone cancer	0.00848	0.00848	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Cisplatin—bone cancer	0.00832	0.00832	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Cisplatin—bone cancer	0.0083	0.0083	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Cisplatin—bone cancer	0.00824	0.00824	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Methotrexate—bone cancer	0.0081	0.0081	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Epirubicin—bone cancer	0.00806	0.00806	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Methotrexate—bone cancer	0.00765	0.00765	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Epirubicin—bone cancer	0.00758	0.00758	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Doxorubicin—bone cancer	0.00746	0.00746	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Cisplatin—bone cancer	0.00732	0.00732	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Methotrexate—bone cancer	0.0073	0.0073	CcSEcCtD
Ceftaroline fosamil—Infestation—Methotrexate—bone cancer	0.0073	0.0073	CcSEcCtD
Ceftaroline fosamil—Pain—Cisplatin—bone cancer	0.00725	0.00725	CcSEcCtD
Ceftaroline fosamil—Renal failure—Methotrexate—bone cancer	0.00717	0.00717	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Epirubicin—bone cancer	0.00716	0.00716	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Doxorubicin—bone cancer	0.00701	0.00701	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Epirubicin—bone cancer	0.00691	0.00691	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Methotrexate—bone cancer	0.0069	0.0069	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Epirubicin—bone cancer	0.00683	0.00683	CcSEcCtD
Ceftaroline fosamil—Infestation—Epirubicin—bone cancer	0.00683	0.00683	CcSEcCtD
Ceftaroline fosamil—Renal failure—Epirubicin—bone cancer	0.00671	0.00671	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Cisplatin—bone cancer	0.0067	0.0067	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Doxorubicin—bone cancer	0.00663	0.00663	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Methotrexate—bone cancer	0.00655	0.00655	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Methotrexate—bone cancer	0.00647	0.00647	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Epirubicin—bone cancer	0.00646	0.00646	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Methotrexate—bone cancer	0.00642	0.00642	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Doxorubicin—bone cancer	0.00639	0.00639	CcSEcCtD
Ceftaroline fosamil—Infestation—Doxorubicin—bone cancer	0.00632	0.00632	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Doxorubicin—bone cancer	0.00632	0.00632	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Cisplatin—bone cancer	0.00625	0.00625	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Epirubicin—bone cancer	0.00624	0.00624	CcSEcCtD
Ceftaroline fosamil—Renal failure—Doxorubicin—bone cancer	0.00621	0.00621	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Epirubicin—bone cancer	0.00613	0.00613	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Epirubicin—bone cancer	0.00605	0.00605	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Epirubicin—bone cancer	0.00601	0.00601	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Doxorubicin—bone cancer	0.00597	0.00597	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Methotrexate—bone cancer	0.00594	0.00594	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Methotrexate—bone cancer	0.00592	0.00592	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Cisplatin—bone cancer	0.0058	0.0058	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Doxorubicin—bone cancer	0.00577	0.00577	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Methotrexate—bone cancer	0.0057	0.0057	CcSEcCtD
Ceftaroline fosamil—Erythema—Methotrexate—bone cancer	0.0057	0.0057	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Doxorubicin—bone cancer	0.00567	0.00567	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Doxorubicin—bone cancer	0.0056	0.0056	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Epirubicin—bone cancer	0.00556	0.00556	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Doxorubicin—bone cancer	0.00556	0.00556	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Epirubicin—bone cancer	0.00554	0.00554	CcSEcCtD
Ceftaroline fosamil—Vomiting—Cisplatin—bone cancer	0.00539	0.00539	CcSEcCtD
Ceftaroline fosamil—Rash—Cisplatin—bone cancer	0.00535	0.00535	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Cisplatin—bone cancer	0.00534	0.00534	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Epirubicin—bone cancer	0.00534	0.00534	CcSEcCtD
Ceftaroline fosamil—Erythema—Epirubicin—bone cancer	0.00534	0.00534	CcSEcCtD
Ceftaroline fosamil—Anaemia—Methotrexate—bone cancer	0.00527	0.00527	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Doxorubicin—bone cancer	0.00515	0.00515	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Doxorubicin—bone cancer	0.00512	0.00512	CcSEcCtD
Ceftaroline fosamil—Nausea—Cisplatin—bone cancer	0.00504	0.00504	CcSEcCtD
Ceftaroline fosamil—Convulsion—Methotrexate—bone cancer	0.00494	0.00494	CcSEcCtD
Ceftaroline fosamil—Erythema—Doxorubicin—bone cancer	0.00494	0.00494	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Doxorubicin—bone cancer	0.00494	0.00494	CcSEcCtD
Ceftaroline fosamil—Anaemia—Epirubicin—bone cancer	0.00493	0.00493	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00482	0.00482	CcSEcCtD
Ceftaroline fosamil—Palpitations—Epirubicin—bone cancer	0.00471	0.00471	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Methotrexate—bone cancer	0.00465	0.00465	CcSEcCtD
Ceftaroline fosamil—Convulsion—Epirubicin—bone cancer	0.00462	0.00462	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Methotrexate—bone cancer	0.00456	0.00456	CcSEcCtD
Ceftaroline fosamil—Anaemia—Doxorubicin—bone cancer	0.00456	0.00456	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Methotrexate—bone cancer	0.00456	0.00456	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Methotrexate—bone cancer	0.00452	0.00452	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00451	0.00451	CcSEcCtD
Ceftaroline fosamil—Palpitations—Doxorubicin—bone cancer	0.00436	0.00436	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Epirubicin—bone cancer	0.00435	0.00435	CcSEcCtD
Ceftaroline fosamil—Convulsion—Doxorubicin—bone cancer	0.00428	0.00428	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Epirubicin—bone cancer	0.00427	0.00427	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Epirubicin—bone cancer	0.00426	0.00426	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Epirubicin—bone cancer	0.00423	0.00423	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00417	0.00417	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Doxorubicin—bone cancer	0.00403	0.00403	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Methotrexate—bone cancer	0.00402	0.00402	CcSEcCtD
Ceftaroline fosamil—Pain—Methotrexate—bone cancer	0.00398	0.00398	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Doxorubicin—bone cancer	0.00395	0.00395	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Doxorubicin—bone cancer	0.00394	0.00394	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Doxorubicin—bone cancer	0.00391	0.00391	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Methotrexate—bone cancer	0.0038	0.0038	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Epirubicin—bone cancer	0.00376	0.00376	CcSEcCtD
Ceftaroline fosamil—Constipation—Epirubicin—bone cancer	0.00372	0.00372	CcSEcCtD
Ceftaroline fosamil—Pain—Epirubicin—bone cancer	0.00372	0.00372	CcSEcCtD
Ceftaroline fosamil—Urticaria—Methotrexate—bone cancer	0.0037	0.0037	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Methotrexate—bone cancer	0.00368	0.00368	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Methotrexate—bone cancer	0.00368	0.00368	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Epirubicin—bone cancer	0.00356	0.00356	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00348	0.00348	CcSEcCtD
Ceftaroline fosamil—Urticaria—Epirubicin—bone cancer	0.00346	0.00346	CcSEcCtD
Ceftaroline fosamil—Pain—Doxorubicin—bone cancer	0.00345	0.00345	CcSEcCtD
Ceftaroline fosamil—Constipation—Doxorubicin—bone cancer	0.00345	0.00345	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Epirubicin—bone cancer	0.00344	0.00344	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Epirubicin—bone cancer	0.00344	0.00344	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Methotrexate—bone cancer	0.00343	0.00343	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Doxorubicin—bone cancer	0.00329	0.00329	CcSEcCtD
Ceftaroline fosamil—Pruritus—Methotrexate—bone cancer	0.00329	0.00329	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Epirubicin—bone cancer	0.00321	0.00321	CcSEcCtD
Ceftaroline fosamil—Urticaria—Doxorubicin—bone cancer	0.0032	0.0032	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Doxorubicin—bone cancer	0.00318	0.00318	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Doxorubicin—bone cancer	0.00318	0.00318	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Methotrexate—bone cancer	0.00318	0.00318	CcSEcCtD
Ceftaroline fosamil—Pruritus—Epirubicin—bone cancer	0.00308	0.00308	CcSEcCtD
Ceftaroline fosamil—Dizziness—Methotrexate—bone cancer	0.00308	0.00308	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Epirubicin—bone cancer	0.00298	0.00298	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Doxorubicin—bone cancer	0.00297	0.00297	CcSEcCtD
Ceftaroline fosamil—Vomiting—Methotrexate—bone cancer	0.00296	0.00296	CcSEcCtD
Ceftaroline fosamil—Rash—Methotrexate—bone cancer	0.00293	0.00293	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Methotrexate—bone cancer	0.00293	0.00293	CcSEcCtD
Ceftaroline fosamil—Headache—Methotrexate—bone cancer	0.00291	0.00291	CcSEcCtD
Ceftaroline fosamil—Dizziness—Epirubicin—bone cancer	0.00288	0.00288	CcSEcCtD
Ceftaroline fosamil—Pruritus—Doxorubicin—bone cancer	0.00285	0.00285	CcSEcCtD
Ceftaroline fosamil—Vomiting—Epirubicin—bone cancer	0.00277	0.00277	CcSEcCtD
Ceftaroline fosamil—Nausea—Methotrexate—bone cancer	0.00276	0.00276	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Doxorubicin—bone cancer	0.00276	0.00276	CcSEcCtD
Ceftaroline fosamil—Rash—Epirubicin—bone cancer	0.00275	0.00275	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Epirubicin—bone cancer	0.00274	0.00274	CcSEcCtD
Ceftaroline fosamil—Headache—Epirubicin—bone cancer	0.00273	0.00273	CcSEcCtD
Ceftaroline fosamil—Dizziness—Doxorubicin—bone cancer	0.00266	0.00266	CcSEcCtD
Ceftaroline fosamil—Nausea—Epirubicin—bone cancer	0.00259	0.00259	CcSEcCtD
Ceftaroline fosamil—Vomiting—Doxorubicin—bone cancer	0.00256	0.00256	CcSEcCtD
Ceftaroline fosamil—Rash—Doxorubicin—bone cancer	0.00254	0.00254	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Doxorubicin—bone cancer	0.00254	0.00254	CcSEcCtD
Ceftaroline fosamil—Headache—Doxorubicin—bone cancer	0.00252	0.00252	CcSEcCtD
Ceftaroline fosamil—Nausea—Doxorubicin—bone cancer	0.00239	0.00239	CcSEcCtD
